Thus, in this study we further examined the expression of IL1RL1 and IL-33 levels using clinical data, and the mechanism of IL-33-mediated p38 MAPK stimulation in the maintenance of AML pediatric patient cells. The gene discussed is IL1RL1; the disease is acute myeloid leukemia.